Harnessing CD16-Mediated NK Cell Functions to Enhance Therapeutic Efficacy of Tumor-Targeting mAbs
Natural killer (NK) cells hold a pivotal role in tumor-targeting monoclonal antibody (mAb)-based activity due to the expression of CD16, the low-affinity receptor for IgG. Indeed, beyond exerting cytotoxic function, activated NK cells also produce an array of cytokines and chemokines, through which...
Main Authors: | Cristina Capuano, Chiara Pighi, Simone Battella, Davide De Federicis, Ricciarda Galandrini, Gabriella Palmieri |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-05-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/13/10/2500 |
Similar Items
-
Impact of SARS-CoV-2 vaccination on FcγRIIIA/CD16 dynamics in Natural Killer cells: relevance for antibody-dependent functions
by: Cristina Capuano, et al.
Published: (2023-11-01) -
(Auto)Antibody Responses Shape Memory NK Cell Pool Size and Composition
by: Cristina Capuano, et al.
Published: (2022-03-01) -
Non-Genetically Improving the Natural Cytotoxicity of Natural Killer (NK) Cells
by: Martin Villalba, et al.
Published: (2020-01-01) -
CAR-NK cell therapy for hematological malignancies: recent updates from ASH 2022
by: Ruihao Huang, et al.
Published: (2023-04-01) -
ADCC against MICA/B Is Mediated against Differentiated Oral and Pancreatic and Not Stem-Like/Poorly Differentiated Tumors by the NK Cells; Loss in Cancer Patients due to Down-Modulation of CD16 Receptor
by: Kawaljit Kaur, et al.
Published: (2021-01-01)